Overview

Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects

Status:
Completed
Trial end date:
2018-06-20
Target enrollment:
Participant gender:
Summary
Bioequivalence Study of 2 formulation of bosentan (Bosentan GEROPHARM vers. Tracleer® Actelion)
Phase:
Phase 1
Details
Lead Sponsor:
Geropharm
Treatments:
Bosentan